COVID-19 Seroprevalence in Pregnant Women and Blood Donors
Completed
- Conditions
- COVID-19 Respiratory Infection
- Registration Number
- NCT04893057
- Lead Sponsor
- Centre Hospitalier Universitaire de Besancon
- Brief Summary
The study aims to measure the SARS-CoV-2 seroprevalence (ie. the proportion of people with antibodies against the virus) in pregnant women and blood donors in an administrative area of France, and to determine whether these measures are representative of the general population.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 797
Inclusion Criteria
-
Pregnant women
- Adult female
- Admitted to hospital for live birth
- Informed consent
- Affiliated to the French social security health insurance scheme
-
Blood donors
- Adult male or female
- Qualified for whole blood donation (up to 70 years old in France)
- Informed consent
- Affiliated to the French social security health insurance scheme
Exclusion Criteria
- Legal incapacity or limited legal capacity
- Subject without health insurance coverage
- Exclusion period of another study or exclusion period of the French national healthy volunteer registry
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Anti-SARS-CoV-2 spike protein total IgG at inclusion Total IgG directed against anti-SARS-CoV-2 spike protein as measured by ELISA assay
- Secondary Outcome Measures
Name Time Method Anti-SARS-CoV-2 nucleocapsid protein total IgG at inclusion Total IgG directed against anti-SARS-CoV-2 nucleocapsid protein as measured by ELISA assay
Trial Locations
- Locations (1)
CHU de besançon
🇫🇷Besançon, France